Eupraxia Pharmaceuticals Inc. (EPRX) has a market capitalization of $241.73M and trades at $7.22. The 52-week range is 2.68-9.32.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.9, Earnings Per Share (EPS) of $-1.05.
The stock has a beta of 1.42, operates in the Healthcare sector.
